MC2 Capital

Watch this space in early 2024 for information about the next MC2 funding round, or, subscribe to our monthly newsletter to learn about all upcoming funding opportunities.

Receive an investment of up to $300,000 CAD from CABHI to grow and scale your healthtech or fintech solution.

Eligible companies may access additional investment of up to $400,000 CAD from the Ontario Brain Institute, $150,000 from Greyhill Capital Partners, commercialization and funding support from Ontario Bioscience Innovation Organization, and business financing from Clearco.

Access Your Capital

Canadian healthtech and fintech companies face an early-stage funding gap. CABHI helps close this gap by enabling access to buyers, subject matter experts, and international markets,
such as those in the US, Japan, or UK.

Each participating company will have access to CABHI’s Acceleration Services and the Ontario Bioscience Innovation Organization’s capital access resources to help grow and scale their solution.

Plus, eligible companies may access additional investment up to $400,000 from the Ontario Brain Institute, $150,000 from , commercialization and funding support from Ontario Bioscience Innovation Organization, and business financing from Clearco .

Companies may also access additional investment opportunities through CABHI’s investor community.

Questions about the program? Contact Jesse Mastrangelo.

*Please note that companies cannot be awarded under both CABHI’s MC2 Capital Program and the Ontario Brain Institute’s NERVE Program at the same time.

Are you an investor? If you’re interested in learning more about investment opportunities with CABHI companies (or those under due diligence), you can request to join CABHI’s investor network here.